Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT05098704Phase 2/3Recruiting
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
SclerodermaSystemic Sclerosis
StudychairStart date: 2022-06-22

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Bordeaux

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Marie-Elise TRUCHETET, Prof

University Hospital, Bordeaux

Moderately Similar
1 trials

Shared therapeutic areas:

Raynaud PhenomenonSclerodermaScleroderma, Systemic

Worked with same sponsors:

Ministry for Health and Solidarity, FranceUniversity Hospital, Bordeaux
Collaborated on 1 trial
Similarity Score34%

Marie-Elise TRUCHETET, MD, PhD

University Hospital, Bordeaux

Related
4 trials

Shared therapeutic areas:

Scleroderma, SystemicScleroderma

Worked with same sponsors:

University Hospital, Bordeaux
Similarity Score20%

Keith Sullivan, MD

Duke University

Related
4 trials

Shared therapeutic areas:

SclerodermaScleroderma, Systemic
Similarity Score20%

Steven Kesten, MD

Cytori Therapeutics

Related
4 trials

Shared therapeutic areas:

SclerodermaScleroderma, Systemic
Similarity Score20%

David Launay, MD,PhD

University Hospital, Lille

Related
9 trials

Shared therapeutic areas:

Scleroderma, SystemicScleroderma
Similarity Score20%

Ruixuan Zhu, MD

Second Xiangya Hospital

Related
1 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score10%

Qiubai Li, Professor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
7 trials

Shared therapeutic areas:

Scleroderma
Similarity Score10%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score10%

Dieter Manstein, MD, PhD

Massachusetts General Hospital

Related
7 trials

Shared therapeutic areas:

Scleroderma
Similarity Score10%

Deran Oskay, Prof

Gazi University

Related
6 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05098704Phase 2/3StudyChair

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

SclerodermaSystemic Sclerosis
Recruiting

All 1 trials loaded